PVARF yields 0.87% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, PVARF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PVARF + JNJ for your $10,000?
Porvair plc, a filtration and environmental technology company, designs, manufactures, and sells filtration and separation equipment primarily in the United Kingdom. It operates in three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment. This segment also produces a range of laboratory microplates, filters, tubing, and associated consumables for use in diagnostics, sample preparation and chromatography applications; and water analysis equipment. The Metal Melt Quality segment designs and manufactures porous ceramic filters for the filtration of molten metals. It provides patent protected filters for the aluminum cast house industry; and the filtration of gray and ductile iron, as well as filtration of super alloy filters used in the manufacture of turbine blades. The company is also involved in trading activities. It also operates in Continental Europe, the United States, South America, Asia, and Africa, as well as other NAFTA countries. Porvair plc was incorporated in 1982 and is headquartered in King's Lynn, the United Kingdom.
Full PVARF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.